EVERYTHING XIAOMI
Get listed

CONVERGE

Place
#9 of 33
Score
5.2
CONVERGE's website

The facts below are what the maker publishes about CONVERGE, checked and dated. Our editors have not written about it yet.

The facts

Each one read from CONVERGE's own pages, with the date it was checked.

What it does

Commercial access
Verge describes engagement models ranging from full target-discovery campaigns to focused human-relevance assessments.checked 14 Nov 2026
Data collection
VergeDB is built from brain tissue partnerships and includes transcriptomic, genetic, clinical, and multi-omics data.checked 14 Nov 2026
Model
Its model infers an individual patient's brain molecular state from a routine blood draw and predicts drug response.checked 14 Nov 2026
Product
CONVERGE is an AI operating system for neuroscience drug development combining foundation models and systems-biology workflows.checked 14 Nov 2026
Program enablement
CONVERGE helps teams evaluate target pathways, patient subgroups, preclinical models, and indication opportunities.checked 14 Nov 2026
Scale
The company's platform data page reports 12,000 brain transcriptomes, 6,000+ neurological patients and controls, and 15M single-cell profiles.checked 14 Nov 2026
Security and integrations
The opened official product pages do not state security certifications or third-party integrations.checked 14 Nov 2026
Support
Verge says it aims to reply to platform and partnership inquiries within two business days.checked 14 Nov 2026
Target discovery
The platform identifies disease signatures and targets using multimodal patient data and human tissue and genetics.checked 14 Nov 2026
Training data
The foundation model is trained on proprietary multimodal CNS patient data and can be tuned with program- and trial-specific data.checked 14 Nov 2026
Users
The product is presented for drug developers working on neuroscience and CNS programs.checked 14 Nov 2026

The company

Company
Verge Labs says it started as Verge Genomics in 2015 and became Verge Labs in 2026.checked 14 Nov 2026
Founded
2015checked 21 Oct 2026
Headquarters
San Francisco, Californiachecked 21 Oct 2026

Money

Trial optimization
It stratifies trial populations by molecular endotype and identifies likely-benefit subgroups and pharmacodynamic biomarkers.checked 14 Nov 2026

Alternatives to CONVERGE

All alternatives
  1. 1

    Boltzmann Labs

    Free planWebAPI
    6.7Free plan
  2. 2
    6.6From $180 a month
  3. 3

    TRION

    Free planWebmacOSWindows
    6.3From $0.01 a month
  4. 4

    BioNeMo

    NVIDIA

    Free planWebAPILinuxSelf-hosted
    6.0Free plan
  5. 5

    StarDrop

    WebLinuxmacOSWindows
    5.7From $10,000 a year
  6. 6
    5.5From $2,500 a month